306 High Throughput Technologies II

Tuesday, November 5, 2013: 12:30 PM
Golden Gate 3 (Hilton)
Description:
The High Throughput Technologies session invites presentations on the latest developments in (1) experimental approaches for measuring high- dimensional data from large number of samples or on genome-scale data sets, (2) computational approaches to automate analysis of such data sets, and (3) application of such approaches to key biomedical systems relevant in biotechnology, disease understanding and therapeutic development. Examples include but are not limited to: novel screening assays for drug discovery and development, next-next-gen high- throughput gene expression measurements, proteomics of large number of samples, etc.

Sponsor:
Engineering Fundamentals in Life Science

Chair:
Kaushal Rege
Email: krege@asu.edu

Co-Chair:
Shannon L. Servoss
Email: sservoss@uark.edu


12:30 PM
(306a) Receptor Tyrosine Kinase Inhibitor Efficacy in Carcinoma Is Stiffness Dependent
Thuy V. Nguyen, William G. Herrick, Marianne Sleiman, Timothy Moriarty and Shelly R. Peyton

12:48 PM
Break

1:06 PM
(306c) Modeling Liver Metabolism for Drug Development
Carrie German and Sundararajan V. Madihally

1:24 PM
(306d) High Throughput Solvent Screening for Ethylcellulose Barrier Membranes in Pharmaceutical Applications
True Rogers, Cody A. Schoener and Jaime Curtis-Fisk

1:42 PM
(306e) High Throughput Fluorescence Decay Measurements Using Time-Resolved Flow Cytometry
Jessica P. Houston, Ruofan Cao, Ali Vaziri, Kevin Houston and Patrick L. Jenkins

2:00 PM
(306f) Developing Droplet Microfluidic-Based High Throughput Screening System for Microbiology
Huiling Yuan, Ran Tu and Qinhong Wang

2:18 PM
(306g) Dynamic Viscoelasticity As a Rapid Single-Cell Biomarker
Tobias Sawetzki, Kevin B. Roth, Aditya Kasukurti, Charles Eggleton, Sanjay A. Desai and David W. M. Marr

2:36 PM
(306h) Computational Recovery of Chromatin Conformations From Experimental Contact Probabilities
Dario Meluzzi and Gaurav Arya
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>